- $3.10bn
- $3.23bn
- $2.35bn
- 99
- 59
- 93
- 97
Annual balance sheet for Amedisys, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 81.8 | 42.7 | 40.5 | 126 | 303 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 260 | 287 | 309 | 328 | 306 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 362 | 357 | 389 | 497 | 632 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 117 | 120 | 119 | 131 | 124 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 1,567 | 1,857 | 1,976 | 2,060 | 2,139 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 456 | 374 | 356 | 474 | 514 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 758 | 926 | 925 | 994 | 1,004 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 809 | 931 | 1,052 | 1,067 | 1,135 |
Total Liabilities & Shareholders' Equity | 1,567 | 1,857 | 1,976 | 2,060 | 2,139 |
Total Common Shares Outstanding |